Your browser doesn't support javascript.
loading
Ponalfil trial for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: Long-term results.
Ribera, Josep-Maria; Morgades, Mireia; Ribera, Jordi; Montesinos, Pau; Cano-Ferri, Isabel; Martínez, Pilar; Esteve, Jordi; Esteban, Daniel; García-Fortes, María; Alonso, Natalia; González-Campos, José; Bermúdez, Arancha; Torrent, Anna; Genescà, Eulàlia; Maluquer, Clara; Martínez-López, Joaquín; García-Sanz, Ramón.
Afiliación
  • Ribera JM; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain.
  • Morgades M; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain.
  • Ribera J; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain.
  • Montesinos P; Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain.
  • Cano-Ferri I; Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain.
  • Martínez P; Department of Hematology Hospital Doce de Octubre Madrid Spain.
  • Esteve J; Department of Hematology Hospital Clínic Barcelona Spain.
  • Esteban D; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain.
  • García-Fortes M; Department of Hematology Hospital Universitario Virgen de la Victoria Málaga Spain.
  • Alonso N; Department of Hematology Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain.
  • González-Campos J; Department of Hematology Hospital Universitario Virgen del Rocío. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/CIBERONC. Universidad de Sevilla Sevilla Spain.
  • Bermúdez A; Department of Hematology Hospital Universitario Marqués de Valdecilla Santander Spain.
  • Torrent A; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain.
  • Genescà E; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain.
  • Maluquer C; Department of Hematology, ICO-Hospital Duran i Reynals Hospitalet de Llobregat Spain.
  • Martínez-López J; Department of Hematology Hospital Doce de Octubre Madrid Spain.
  • García-Sanz R; Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC) Salamanca Spain.
Hemasphere ; 8(4): e67, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38566805
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Hemasphere Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Hemasphere Año: 2024 Tipo del documento: Article